Aterian (ATER) Expected to Announce Earnings on Thursday

Aterian (NASDAQ:ATERGet Free Report) is expected to announce its Q2 2026 results before the market opens on Thursday, August 13th. Analysts expect Aterian to post earnings of ($0.17) per share and revenue of $20.3050 million for the quarter. Individuals may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 19, 2026 at 5:00 PM ET.

Aterian (NASDAQ:ATERGet Free Report) last issued its earnings results on Friday, May 15th. The company reported ($0.39) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.69) by $0.30. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.The firm had revenue of $0.02 million for the quarter, compared to analysts’ expectations of $15.82 million.

Aterian Trading Down 2.7%

NASDAQ:ATER opened at $0.48 on Tuesday. The stock has a market cap of $5.22 million, a price-to-earnings ratio of -0.19 and a beta of 0.78. The stock has a 50-day moving average price of $1.01 and a two-hundred day moving average price of $0.85. Aterian has a 1 year low of $0.35 and a 1 year high of $1.87.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. XTX Topco Ltd purchased a new stake in shares of Aterian during the second quarter worth $55,000. Goldman Sachs Group Inc. lifted its position in Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares during the last quarter. Susquehanna International Group LLP increased its stake in Aterian by 310.2% in the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after acquiring an additional 30,637 shares during the last quarter. Finally, Citadel Advisors LLC boosted its holdings in shares of Aterian by 222.0% in the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after purchasing an additional 22,865 shares in the last quarter. Hedge funds and other institutional investors own 7.02% of the company’s stock.

Wall Street Analyst Weigh In

ATER has been the subject of several recent research reports. Weiss Ratings raised Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 19th. Wall Street Zen downgraded Aterian from a “hold” rating to a “sell” rating in a research note on Saturday, July 25th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Aterian currently has an average rating of “Sell”.

Check Out Our Latest Analysis on Aterian

About Aterian

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Featured Stories

Earnings History for Aterian (NASDAQ:ATER)

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.